These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8382386)

  • 1. Immunosuppression by delta opioid receptor antagonist.
    Arakawa K; Akami T; Okamoto M; Akioka K; Nakai I; Oka T; Nagase H
    Transplant Proc; 1993 Feb; 25(1 Pt 1):738-40. PubMed ID: 8382386
    [No Abstract]   [Full Text] [Related]  

  • 2. The immunosuppressive effect of delta-opioid receptor antagonist on rat renal allograft survival.
    Arakawa K; Akami T; Okamoto M; Oka T; Nagase H; Matsumoto S
    Transplantation; 1992 Apr; 53(4):951-3. PubMed ID: 1314442
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunosuppressive effect of delta-opioid receptor antagonist on xenogeneic mixed lymphocyte reaction.
    Arakawa K; Akami T; Okamoto M; Nakajima H; Mitsuo M; Nakai I; Oka T; Nagase H; Matsumoto S
    Transplant Proc; 1992 Apr; 24(2):696-7. PubMed ID: 1314443
    [No Abstract]   [Full Text] [Related]  

  • 4. The delta1-opioid receptor antagonist, 7-(benzospiroindanyl)naltrexone [correction of 7-benzylspiroindanylnaltrexone], prolongs renal allograft survival in a rat model.
    Linner KM; Stickney BJ; Quist HE; Sharp BM; Portoghese PS
    Eur J Pharmacol; 1998 Jul; 354(1):R3-5. PubMed ID: 9726640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo use of rapamycin suppresses neither IL-2 production nor IL-2 receptor expression in rat transplant model.
    Hamashima T; Yoshimura N; Ohsaka Y; Oka T; Stepkowski SM; Kahan BD
    Transplant Proc; 1993 Feb; 25(1 Pt 1):723-4. PubMed ID: 8438457
    [No Abstract]   [Full Text] [Related]  

  • 6. Biological characteristics of a novel immunosuppressant, IR-1116, specific for B lymphocytes.
    Matsumoto S; Marui S; Shiho O; Tsukamoto K; Yoshimura N; Oka T
    Transplant Proc; 1993 Feb; 25(1 Pt 1):734-7. PubMed ID: 8382385
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunosuppression by delta-opioid antagonist naltrindole: delta- and triple mu/delta/kappa-opioid receptor knockout mice reveal a nonopioid activity.
    Gavériaux-Ruff C; Filliol D; Simonin F; Matthes HW; Kieffer BL
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1193-8. PubMed ID: 11504820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A remarkable change of opioid receptor selectivity on the attachment of a peptidomimetic kappa address element to the delta antagonist, natrindole: 5'-[N2-alkylamidino)methyl]naltrindole derivatives as a novel class of kappa opioid receptor antagonists.
    Olmsted SL; Takemori AE; Portoghese PS
    J Med Chem; 1993 Jan; 36(1):179-80. PubMed ID: 8380614
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunosuppressive effects of bactobolamine in vitro and in vivo.
    Tomikawa S; Beck Y; Watanabe K; Kikuchi K; Ito S; Ando Y; Ichikawa N; Meigata K; Nomura Y; Degawa H; Nagao T; Uchida H
    Transplant Proc; 1996 Apr; 28(2):1049-51. PubMed ID: 8623223
    [No Abstract]   [Full Text] [Related]  

  • 10. Liver sinusoidal passenger lymphocytes reveal suppressive properties and prolong allograft survival.
    Olszewski WL; Jasklowska-Englisz M; Sadowska-Ryffa D; Lukomska B; Maksymowicz M
    Transplant Proc; 1995 Feb; 27(1):194-5. PubMed ID: 7878970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of delta-opioid receptors in the nucleus accumbens prevents ethanol-induced stimulation of dopamine release.
    Acquas E; Meloni M; Di Chiara G
    Eur J Pharmacol; 1993 Jan; 230(2):239-41. PubMed ID: 8380771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of the immunosuppressive effect of SMS 201-995 and its synergic action with FK 506.
    Perego C; Lattuada D; Casnici C; Gatti S; Orsenigo R; Panagiotis S; Franco P; Marelli O
    Transplant Proc; 1998 Aug; 30(5):2182-4. PubMed ID: 9723434
    [No Abstract]   [Full Text] [Related]  

  • 13. Spleen mixed leukocyte chimerism and induction of tolerance in rat renal allograft recipients conditioned with donor-specific blood transfusions and cyclosporine.
    Llull R; Mañez R; Domenech N; Starzl TE; Black KS; Hewitt CW
    Transplant Proc; 1995 Aug; 27(4):2374-6. PubMed ID: 7652844
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of FK 506 and donor-specific blood transfusion on the rat composite tissue limb allograft and the mechanism of long-term graft survival.
    Kuroki H; Bean MA; Ikuta Y; Akiyama M; Burgess EM
    Transplant Proc; 1993 Feb; 25(1 Pt 1):658-61. PubMed ID: 7679833
    [No Abstract]   [Full Text] [Related]  

  • 15. Binding, pharmacological and immunological profiles of the delta-selective opioid receptor antagonist HS 378.
    Spetea M; Harris HE; Berzetei-Gurske IP; Klareskog L; Schmidhammer H
    Life Sci; 2001 Aug; 69(15):1775-82. PubMed ID: 11665839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring delta-receptor function using the selective opioid antagonist naltrindole.
    Jackson HC; Ripley TL; Nutt DJ
    Neuropharmacology; 1989 Dec; 28(12):1427-30. PubMed ID: 2559353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cocaine place preference is blocked by the delta-opioid receptor antagonist, naltrindole.
    Menkens K; Bilsky EJ; Wild KD; Portoghese PS; Reid LD; Porreca F
    Eur J Pharmacol; 1992 Aug; 219(2):345-6. PubMed ID: 1425962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo and in vitro investigation of naltrindole, a delta-opioid antagonist.
    Ayres EA; Davis P; Burks TF
    Proc West Pharmacol Soc; 1990; 33():55-63. PubMed ID: 2177196
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum suppressive factor appears to potentiate cardiac allograft survival after portal vein injection of ultraviolet B-irradiated donor spleen cells.
    Yu S; Nakafusa Y; Flye MW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):500-1. PubMed ID: 8438394
    [No Abstract]   [Full Text] [Related]  

  • 20. FK 506 and deoxyspergualin: additive immunosuppressive effect on rat cardiac allograft rejection in vivo and mitogen-stimulated human lymphocyte responses in vitro.
    Jiang H; Takahara S; Li D; Namiki M; Ishibashi M; Okuyama A; Sonoda T
    Transplant Proc; 1994 Aug; 26(4):2313-6. PubMed ID: 7520631
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.